Close
  Indian J Med Microbiol
 

Figure 2: In vitro drug release profiles of nanoparticle formulations containing low molecular weight heparin prepared using different concentrations of polylactide co-glycolide 85:15 (150, 200 mg) and different concentrations of surfactant (0.1%, 0.5%, 1%)

Figure 2: <i>In vitro</i> drug release profiles of nanoparticle formulations containing low molecular weight heparin prepared using different concentrations of polylactide co-glycolide 85:15 (150, 200 mg) and different concentrations of surfactant (0.1%, 0.5%, 1%)